SCHEMBL23090371

SCHEMBL23090371

COc1cc2c(cc1C(=O)Nc1ccc(-c3ccccc3)cc1)CCCCC2

nearest known ligand 0.71

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ DHODH Q02127 4/20 0.71
▸ NR1H4 Q96RI1 1/20 0.60
▸ KMT2A Q03164 10/20 0.56
▸ MEN1 O00255 7/20 0.56
▸ RAB9A P51151 7/20 0.56
▸ LMNA P02545 2/20 0.56
▸ SMN1; SMN2 Q16637 2/20 0.56
▸ NPC1 O15118 7/20 0.53
▸ ABCC1 P33527 1/20 0.53
▸ AHR P35869 3/20 0.52
▸ POLB P06746 2/20 0.52
▸ MAPT P10636 3/20 0.52
▸ GFER P55789 2/20 0.52
▸ ABCB1 P08183 1/20 0.50
▸ MAPK14 Q16539 1/20 0.50
▸ TP53 P04637 1/20 0.49
▸ TSHR P16473 1/20 0.49
▸ MAPK1 P28482 1/20 0.49
▸ HTT P42858 1/20 0.48
▸ NPSR1 Q6W5P4 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23090386 0.84 ABCB1 (0.61) DHODHKMT2AMEN1RAB9ALMNA
SCHEMBL23090382 0.83 DHODH (1.00) DHODHNR1H4KMT2AMEN1RAB9A
SCHEMBL23090409 0.82 DHODH (0.63) DHODHNR1H4KMT2AMEN1RAB9A
SCHEMBL23090367 0.82 DHODH (1.00) DHODHNR1H4KMT2AMEN1RAB9A
SCHEMBL23090385 0.80 DHODH (0.70) DHODHKMT2AMEN1RAB9ALMNA
SCHEMBL23090379 0.79 DHODH (0.78) DHODHNR1H4KMT2AMEN1RAB9A
SCHEMBL23090415 0.79 MEN1 (0.62) DHODHKMT2AMEN1RAB9ALMNA
SCHEMBL23090416 0.78 DHODH (1.00) DHODHNR1H4KMT2AMEN1RAB9A
SCHEMBL23090368 0.74 DHODH (0.53) DHODHKMT2AMEN1RAB9ALMNA
SCHEMBL23090366 0.74 DHODH (0.57) DHODHKMT2AMEN1RAB9ALMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11066357-B2 Benzoannulene derivatives as antiviral agents SOUTHERN RESEARCH INSTITUTE (US) 2021-07-20 — — US disclosed
US-11066357-B2 Benzoannulene derivatives as antiviral agents SOUTHERN RESEARCH INSTITUTE (US) 2021-07-20 — — US disclosed
US-20210078937-A1 BENZOANNULENE DERIVATIVES AS ANTIVIRAL AGENTS SOUTHERN RESEARCH INSTITUTE 2021-03-18 — — US disclosed
US-20210078937-A1 BENZOANNULENE DERIVATIVES AS ANTIVIRAL AGENTS SOUTHERN RESEARCH INSTITUTE 2021-03-18 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210078937-A1 BENZOANNULENE DERIVATIVES AS ANTIVIRAL AGENTS ZC3HAV1, MAVS, ZC3HAV1L DHODH 344/4885NR1H4 3648/4885KMT2A 3836/4885
US-11066357-B2 Benzoannulene derivatives as antiviral agents ZC3HAV1, MAVS, ZC3HAV1L DHODH 344/4885NR1H4 3648/4885KMT2A 3836/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback